作者
Kenneth Aldape, Kevin M Brindle, Louis Chesler, Rajesh Chopra, Amar Gajjar, Mark R Gilbert, Nicholas Gottardo, David H Gutmann, Darren Hargrave, Eric C Holland, David TW Jones, Johanna A Joyce, Pamela Kearns, Mark W Kieran, Ingo K Mellinghoff, Melinda Merchant, Stefan M Pfister, Steven M Pollard, Vijay Ramaswamy, Jeremy N Rich, Giles W Robinson, David H Rowitch, John H Sampson, Michael D Taylor, Paul Workman, Richard J Gilbertson
发表日期
2019/8
来源
Nature reviews Clinical oncology
卷号
16
期号
8
页码范围
509-520
出版商
Nature Publishing Group UK
简介
Despite decades of research, brain tumours remain among the deadliest of all forms of cancer. The ability of these tumours to resist almost all conventional and novel treatments relates, in part, to the unique cell-intrinsic and microenvironmental properties of neural tissues. In an attempt to encourage progress in our understanding and ability to successfully treat patients with brain tumours, Cancer Research UK convened an international panel of clinicians and laboratory-based scientists to identify challenges that must be overcome if we are to cure all patients with a brain tumour. The seven key challenges summarized in this Position Paper are intended to serve as foci for future research and investment.
引用总数
学术搜索中的文章
K Aldape, KM Brindle, L Chesler, R Chopra, A Gajjar… - Nature reviews Clinical oncology, 2019